Hui-Hua Chen Selected Research

stachydrine

1/2022	Stachydrine hydrochloride ameliorates cardiac hypertrophy through CaMKII/HDAC4/MEF2C signal pathway.
2/2020	Stachydrine hydrochloride alleviates pressure overload-induced heart failure and calcium mishandling on mice.
1/2017	Stachydrine Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Suppressing Autophagy.
1/2017	Stachydrine ameliorates pressure overload-induced diastolic heart failure by suppressing myocardial fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Hua Chen Research Topics

Disease

4	Neoplasms (Cancer) 05/2022 - 01/2019
4	Fibrosis (Cirrhosis) 01/2019 - 01/2016
3	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2017
3	Hypertrophy 01/2022 - 01/2016
2	Lymphatic Metastasis 04/2022 - 01/2020
2	Endometrial Neoplasms (Endometrial Cancer) 04/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
2	Heart Failure 02/2020 - 01/2017
1	Hypotension (Low Blood Pressure) 07/2020
1	Uterine Hemorrhage (Uterine Bleeding) 07/2020
1	Postpartum Hemorrhage 07/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Fatigue 07/2019
1	Neoplasm Metastasis (Metastasis) 06/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2019
1	Lymphocele 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Diastolic Heart Failure 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Diabetic Cardiomyopathies 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 07/2006
1	Carcinogenesis 07/2006

Drug/Important Bio-Agent (IBA)

4	stachydrineIBA 01/2022 - 01/2017
3	Therapeutic UsesIBA 01/2022 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
2	TubulinIBA 01/2022 - 01/2017
2	CollagenIBA 01/2019 - 01/2017
1	Hematoxylin (Haematoxylon)IBA 04/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2022
1	Keratins (Keratin)IBA 04/2022
1	Coloring Agents (Dyes)IBA 04/2022
1	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022
1	Shenghua DecoctionIBA 07/2020
1	CalciumIBA 02/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	PlatinumIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Furaldehyde (Furfural)IBA 07/2019
1	5-hydroxymethylfurfural (hydroxymethylfurfural)IBA 07/2019
1	Cadherins (E-Cadherin)IBA 06/2019
1	Lysine (L-Lysine)FDA Link 06/2019
1	MethyltransferasesIBA 06/2019
1	Indicators and Reagents (Reagents)IBA 06/2019
1	Bone Morphogenetic Protein 7IBA 01/2019
1	danggui-shaoyao-sanIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017
1	glycyrrhizae radix et rhizomaIBA 01/2017
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 01/2016
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2006

Therapy/Procedure

3	Radiotherapy 05/2022 - 01/2019
2	Lymph Node Excision (Lymph Node Dissection) 04/2022 - 01/2019
1	Therapeutics 05/2022
1	Hysterectomy 07/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Adjuvant Chemotherapy 01/2020
1	Chemoradiotherapy 01/2020
1	Oral Administration 01/2016
1	Subcutaneous Injections 07/2006